Authors: Bosquet, F Heurtier, A Chastang, N Jacqueminet, S

Citation: F. Bosquet et al., Insulin status and adjustment in type 2 diabetic patients' treatment., REV MED IN, 22(3), 2001, pp. 265-273

Authors: Vizler, C Bercovici, N Heurtier, A Pardigon, N Goude, K Bailly, K Combadiere, C Liblau, RS

Citation: C. Vizler et al., Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hosts, J IMMUNOL, 165(11), 2000, pp. 6314-6321

Authors: Bercovici, N Heurtier, A Vizler, C Pardigon, N Cambouris, C Desreumaux, P Liblau, R

Citation: N. Bercovici et al., Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage, J IMMUNOL, 165(1), 2000, pp. 202-210

Authors: Van, GH Heurtier, A Greau, F Menou, P Grimaldi, A

Citation: Gh. Van et al., How to manage the off-loading of a chronic diabetic foot ulcer?, DIABETE MET, 25(3), 1999, pp. 264-269

Authors: Grimaldi, A Heurtier, A

Citation: A. Grimaldi et A. Heurtier, Epidemiology of cardiovascular complications in diabetes mellitus., DIABETE MET, 25, 1999, pp. 12-20

Authors: Sachon, C Heurtier, A Grimaldi, A

Citation: C. Sachon et al., The concept of "functional" insulin treatment., DIABETE MET, 24(6), 1998, pp. 556-559